Compare IL&FS INV. MANAGERS with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IL&FS INV. MANAGERS vs INDOCO REMEDIES - Comparison Results

IL&FS INV. MANAGERS     Change

IL&FS Investment Managers Limited (IIML) is a subsidiary of Infrastructure Leasing & Financial Services Limited (IL&FS). It was founded as Credit Capital Venture Fund (CCVF) in 1989, as an affiliate of Lazard Brothers. It was then later acquired by I... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IL&FS INV. MANAGERS INDOCO REMEDIES IL&FS INV. MANAGERS/
INDOCO REMEDIES
 
P/E (TTM) x -38.3 127.1 - View Chart
P/BV x 0.4 2.1 18.1% View Chart
Dividend Yield % 13.5 0.6 2,121.7%  

Financials

 IL&FS INV. MANAGERS   INDOCO REMEDIES
EQUITY SHARE DATA
    IL&FS INV. MANAGERS
Mar-18
INDOCO REMEDIES
Mar-18
IL&FS INV. MANAGERS/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs35317 11.1%   
Low Rs14178 7.6%   
Sales per share (Unadj.) Rs3.6113.1 3.2%  
Earnings per share (Unadj.) Rs0.24.5 4.7%  
Cash flow per share (Unadj.) Rs0.611.8 4.9%  
Dividends per share (Unadj.) Rs0.601.00 60.0%  
Dividend yield (eoy) %2.50.4 609.2%  
Book value per share (Unadj.) Rs11.473.2 15.6%  
Shares outstanding (eoy) m314.0392.15 340.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.82.2 310.9%   
Avg P/E ratio x116.855.5 210.6%  
P/CF ratio (eoy) x42.421.0 202.2%  
Price / Book Value ratio x2.13.4 63.1%  
Dividend payout %287.222.4 1,282.9%   
Avg Mkt Cap Rs m7,66222,830 33.6%   
No. of employees `000NA5.5 0.8%   
Total wages/salary Rs m4252,209 19.2%   
Avg. sales/employee Rs Th27,437.31,910.1 1,436.5%   
Avg. wages/employee Rs Th10,356.1405.0 2,557.3%   
Avg. net profit/employee Rs Th1,600.075.5 2,120.5%   
INCOME DATA
Net Sales Rs m1,12510,419 10.8%  
Other income Rs m10147 214.7%   
Total revenues Rs m1,22610,466 11.7%   
Gross profit Rs m2281,349 16.9%  
Depreciation Rs m115677 17.0%   
Interest Rs m0235 0.0%   
Profit before tax Rs m214484 44.2%   
Minority Interest Rs m-290-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11972 164.9%   
Profit after tax Rs m66412 15.9%  
Gross profit margin %20.312.9 156.7%  
Effective tax rate %55.815.0 373.2%   
Net profit margin %5.84.0 147.6%  
BALANCE SHEET DATA
Current assets Rs m2,9365,373 54.6%   
Current liabilities Rs m2414,157 5.8%   
Net working cap to sales %239.611.7 2,052.9%  
Current ratio x12.21.3 944.4%  
Inventory Days Days068 0.0%  
Debtors Days Days33473 458.9%  
Net fixed assets Rs m4816,244 7.7%   
Share capital Rs m628184 340.8%   
"Free" reserves Rs m2,9646,566 45.1%   
Net worth Rs m3,5926,750 53.2%   
Long term debt Rs m01,233 0.0%   
Total assets Rs m3,41712,363 27.6%  
Interest coverage xNM3.1-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.30.8 39.1%   
Return on assets %1.95.2 36.7%  
Return on equity %1.86.1 29.9%  
Return on capital %5.29.0 57.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m-1091,227 -8.9%  
From Investments Rs m-101-1,360 7.4%  
From Financial Activity Rs m-195-388 50.4%  
Net Cashflow Rs m-406-521 77.9%  

Share Holding

Indian Promoters % 50.5 59.2 85.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 12.5 29.4%  
FIIs % 0.4 6.0 6.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.4 22.4 202.7%  
Shareholders   31,147 12,805 243.2%  
Pledged promoter(s) holding % 100.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IL&FS INV. MANAGERS With:   JSW HOLDINGS  INDIABULLS FIN. SER.  INGERSOLL RAND  COX & KINGS  COMMEX TECHNOLOGY  



Today's Market

Indian Indices Continue Downtrend, Developments From the IPO Space, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets fell sharply during closing hours amid fears of rising crude oil prices and weakness in the rupee.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

IL&FS INV. MANAGERS 2017-18 Annual Report Analysis (Annual Result Update)

Jan 7, 2019 | Updated on Jan 7, 2019

Here's an analysis of the annual report of IL&FS INV. MANAGERS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of IL&FS INV. MANAGERS. Also includes updates on the valuation of IL&FS INV. MANAGERS.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IL&FS INV. MANAGERS SHARE PRICE


Sep 17, 2019 (Close)

TRACK IL&FS INV. MANAGERS

  • Track your investment in IL&FS INV. MANAGERS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IL&FS INV. MANAGERS

IL&FS INV. MANAGERS 5-YR ANALYSIS

COMPARE IL&FS INV. MANAGERS WITH

MARKET STATS